Disparate Roles for TNF-α and Fas Ligand in Concanavalin A-Induced Hepatitis
暂无分享,去创建一个
L. Moldawer | D. Colagiovanni | C. Edwards | C. Solórzano | M. Clare-Salzler | C. Tannahill | J. Norman | W. Denham | R. Ksontini | S. Mackay | M. Josephs
[1] Y. Iwakura,et al. Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. , 1997, Journal of immunology.
[2] L. Moldawer,et al. A MATRIX METALLOPROTEINASE INHIBITOR PREVENTS PROCESSING OF TUMOR NECROSIS FACTOR α (TNFα) AND ABROGATES ENDOTOXIN‐INDUCED LETHALITY , 1997 .
[3] S. Nagata,et al. Essential roles of the Fas ligand in the development of hepatitis , 1997, Nature Medicine.
[4] R. Kamen,et al. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN- γ production , 1997, Nature.
[5] M. Lambert,et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α , 1997, Nature.
[6] Nicole Nelson,et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells , 1997, Nature.
[7] S. Nagata,et al. Apoptosis by Death Factor , 1997, Cell.
[8] J. Vauthey,et al. Involvement of 26-kDa cell-associated TNF-alpha in experimental hepatitis and exacerbation of liver injury with a matrix metalloproteinase inhibitor. , 1997, Journal of immunology.
[9] Douglas K. Miller,et al. The interleukin‐1β converting enzyme family of cysteine proteases , 1997 .
[10] S. Nagata,et al. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death , 1996, The Journal of experimental medicine.
[11] Junying Yuan,et al. Human ICE/CED-3 Protease Nomenclature , 1996, Cell.
[12] J. Mountz,et al. Autoimmune disease results from multiple interactive defects in apoptosis induction molecules and signaling pathways. , 1996, Behring Institute Mitteilungen.
[13] G. Gerken,et al. Role of sinusoidal endothelial cells of the liver in concanavalin A‐induced hepatic injury in mice , 1996, Hepatology.
[14] T. Akaike,et al. Concanavalin A induces perforin‐mediated but not Fas‐mediated hepatic injury , 1996, Hepatology.
[15] P. Kiener,et al. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils , 1996, The Journal of experimental medicine.
[16] S. Küsters,et al. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. , 1996, Gastroenterology.
[17] G. Evan,et al. A License to Kill , 1996, Cell.
[18] A. H. Drummond,et al. Fas ligand in human serum , 1996, Nature Medicine.
[19] K. Yoshino,et al. Metalloproteinase-mediated Release of Human Fas Ligand , 1995 .
[20] D. Green,et al. Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege , 1995, Science.
[21] P. Galle,et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage , 1995, The Journal of experimental medicine.
[22] Seamus J. Martin,et al. Protease activation during apoptosis: Death by a thousand cuts? , 1995, Cell.
[23] S. Lowry,et al. PEG-BP-30 monotherapy attenuates the cytokine-mediated inflammatory cascade in baboon Escherichia coli septic shock. , 1995, The Journal of surgical research.
[24] J. Cleveland,et al. Contenders in FasL/TNF death signaling , 1995, Cell.
[25] W. Fiers,et al. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis , 1995, Nature.
[26] S. Nagata,et al. Involvement of an ICE-like protease in Fas-mediated apoptosis , 1995, Nature.
[27] T. Yokota,et al. Expression of the Fas ligand in cells of T cell lineage. , 1995, Journal of immunology.
[28] M. Su,et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. , 1995, Science.
[29] M. Leist,et al. Concanavalin A—induced T‐cell—mediated hepatic injury in mice: The role of tumor necrosis factor , 1995, Hepatology.
[30] L. Steinman,et al. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. , 1994, The Journal of clinical investigation.
[31] E. O’Neill,et al. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6 , 1994, The Journal of experimental medicine.
[32] P. Golstein,et al. Fas‐based lymphocyte‐mediated cytotoxicity against syngeneic activated lymphocytes: A regulatory pathway? , 1994, European journal of immunology.
[33] N. Jenkins,et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand , 1994, Cell.
[34] Shai Shaham,et al. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme , 1993, Cell.
[35] S. Nagata,et al. Lethal effect of the anti-Fas antibody in mice , 1993, Nature.
[36] D. Grobelny,et al. Inhibition of human skin fibroblast collagenase, thermolysin, and Pseudomonas aeruginosa elastase by peptide hydroxamic acids. , 1992, Biochemistry.
[37] A. Wendel,et al. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. , 1992, The Journal of clinical investigation.
[38] L. Moldawer,et al. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[39] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[40] J. W. Becker,et al. The interleukin-1 beta converting enzyme family of cysteine proteases. , 1997, Journal of Cellular Biochemistry.
[41] R. Kamen,et al. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. , 1997, Nature.
[42] L. Moldawer,et al. A matrix metalloproteinase inhibitor prevents processing of tumor necrosis factor alpha (TNF alpha) and abrogates endotoxin-induced lethality. , 1997, Shock.
[43] B. Castner,et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. , 1997, Nature.
[44] M. Leist,et al. The 55-kD Tumor Necrosis Factor Receptor and CD95 Independently Signal Murine Hepatocyte Apoptosis and Subsequent Liver Failure , 1996, Molecular medicine.
[45] S. Nagata. Apoptosis mediated by the Fas system. , 1996, Progress in molecular and subcellular biology.
[46] T. van der Poll,et al. Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense? , 1995, Shock.